Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan)
Dec 14, 2016 13:05 pm UTC| Business
SAN DIEGO, Dec. 14, 2016 -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology,...
Willis Towers Watson appoints Mary O’Connor to lead Client and Business Development in Great Britain
Dec 14, 2016 13:03 pm UTC| Business
LONDON, Dec. 14, 2016 -- Willis Towers Watson is pleased to announce that Mary O'Connor will lead the Client and Business Development function for Willis Towers Watson Great Britain. Mary also continues to co-lead the...
Dec 14, 2016 13:00 pm UTC| Business
RedHill and its co-development partner, IntelGenxCorp. (IntelGenx), have signed a definitive agreement with Pharmatronic Co., granting an exclusive license to commercialize the acute migraine drug RIZAPORT® in South...
InvisibleShield Introduces Glass+ Luxe and Glass+ Privacy Screen Protectors for iPhone
Dec 14, 2016 13:00 pm UTC| Business
SALT LAKE CITY, Dec. 14, 2016 -- InvisibleShield®, the leading global brand and innovator in screen protection, today expanded its lineup of Glass+ tempered glass screen protectors by announcing Glass+ Luxe™ and Glass+...
Postman Announces Postman Pro: Complete API Toolchain for Developers & Developer Teams
Dec 14, 2016 13:00 pm UTC| Business
SAN FRANCISCO, Dec. 14, 2016 -- Postman, provider of the most popular API toolchain available, today announced a major update to its innovative developer product, Postman Pro. In limited release since early this year as...
Dec 14, 2016 13:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 14, 2016 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced that the...
Argos Therapeutics Enters into Strategic Research Agreement with Personalis, Inc.
Dec 14, 2016 13:00 pm UTC| Business
DURHAM, N.C., Dec. 14, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...